Srb Corp Bristol Myers Squibb CO Transaction History

Srb Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $54,879 - $61,364	948 Added 14.28%	7,585 $440,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $99,196 - $110,142	1,557 Added 30.65%	6,637 $424,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $48,231 - $54,705	-734 Reduced 12.62%	5,080 $352,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $755 - $446,747	5,814 New	5,814 $414,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $640,830 - $931,275	-13,811 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $209,290 - $273,000	4,253 Added 44.5%	13,811 $887,000
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $33,232 - $39,401	-777 Reduced 7.52%	9,558 $484,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $461,147 - $509,928	10,335 New	10,335 $469,000
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $186,411 - $214,596	-3,111 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $12,702 - $14,660	-230 Reduced 6.88%	3,111 $198,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,341	3,341 $186,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

Stay updated on Srb Corp with notifications on news.